GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition
Mengxin Li, Xuanzhong Wang, Xuyang Chen, Jinghui Hong, Du Ye, Dong Eun Song
Topics & Concepts
Pancreatic cancerCisplatinEpithelial–mesenchymal transitionCancer researchApoptosisIn vivoCell cycleChemotherapyCell growthCancerPharmacologyMedicineBiologyMetastasisInternal medicineBiochemistryBiotechnologyBlood properties and coagulationPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment